These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use and safety of high-dose ifosfamide. Holoye PY; Anderson T; Duelge J; Hansen RM; Ritch PS Semin Oncol; 1982 Dec; 9(4 Suppl 1):78-86. PubMed ID: 6298946 [No Abstract] [Full Text] [Related]
24. Ifosfamide vs cyclophosphamide in cancer therapy. Weiss RB Oncology (Williston Park); 1991 May; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004 [TBL] [Abstract][Full Text] [Related]
25. Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease. Sutton GP; Soper JT; Blessing JA; Hatch KD; Barnhill DR Am J Obstet Gynecol; 1992 Aug; 167(2):489-95. PubMed ID: 1323213 [TBL] [Abstract][Full Text] [Related]
26. Relapse of adult acute lymphoblastic leukaemia treated with ifosfamide combination chemotherapy. Timonen TT Cancer Treat Rev; 1983 Sep; 10 Suppl A():145-50. PubMed ID: 6578874 [No Abstract] [Full Text] [Related]
27. Ifosfamide in the treatment of bronchogenic carcinoma. A preliminary trial. Gandola L; Pozzi E; Tansini G G Ital Chemioter; 1978; 25(1):41-4. PubMed ID: 376387 [No Abstract] [Full Text] [Related]
33. Ifosfamide-based chemotherapy for previously treated lung cancer patients. Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391 [TBL] [Abstract][Full Text] [Related]
34. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
35. The role of ifosfamide in the treatment of lymphomas. Hagemeister FB Leuk Lymphoma; 1999 Aug; 34(5-6):433-41. PubMed ID: 10492066 [TBL] [Abstract][Full Text] [Related]
36. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States. Pratt CB Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456 [TBL] [Abstract][Full Text] [Related]
37. Ifosfamide. Zalupski M; Baker LH J Natl Cancer Inst; 1988 Jun; 80(8):556-66. PubMed ID: 3286879 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide. Schnitker J; Brock N; Burkert H; Fichtner E Arzneimittelforschung; 1976; 26(10):1783-92. PubMed ID: 798586 [TBL] [Abstract][Full Text] [Related]
39. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588). Ettinger DS; Finkelstein DM; Ritch PS; Lincoln ST; Blum RH; Lung Cancer; 2002 Sep; 37(3):311-8. PubMed ID: 12234701 [TBL] [Abstract][Full Text] [Related]
40. The anticancer spectrum of ifosfamide. Hunter HL; Harrison EF Semin Oncol; 1982 Dec; 9(4 Suppl 1):96-100. PubMed ID: 6761868 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]